GETUG-AFU 31: a phase I/II multicentre study evaluating the safety and efficacy of salvage stereotactic radiation in patients with intraprostatic tumour recurrence after external radiation therapy—study protocol
Introduction Prostate cancer is the third most important cancer in terms of mortality in men. No standard local treatment exists for patients with an intraprostatic recurrence after radiotherapy. Stereotatic body radiotherapy (SBRT) could be a curative treatment for local recurrence. The phase I/II...
Saved in:
| Main Authors: | Marie-Cécile Le Deley, David Pasquier, Emmanuelle Tresch, Luc Cormier, Martine Duterque, Soazig Nenan, Eric Lartigau |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-08-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/9/8/e026666.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stereotactic body radiation therapy in hepatocellular carcinoma
by: Gagan Saini
Published: (2020-01-01) -
REPAIR_GETUG P16 relapse in previously irradiated prostate bed: a phase I/II study of stereotactic ablative reirradiation potentiated by a metformine study protocol
by: Alexandre Joly, et al.
Published: (2025-07-01) -
Stereotactic body radiation therapy for colorectal liver metastases
by: Issa Mohamad, et al.
Published: (2022-12-01) -
Stereotactic body radiation therapy for inoperable localized kidney cancer
by: Zh. E. Sabelnikova, et al.
Published: (2023-05-01) -
Combined stereotactic radiation therapy and immunotherapy for metastatic uveal melanoma
by: Valeria V. Nazarova, et al.
Published: (2025-05-01)